Pernod Ricard (RI) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
27 Aug, 2026Executive summary
FY26 faced a challenging environment with organic net sales down 3.9% (reported -14.2%), softness in the US and China, and Middle East conflict impacting Q4, partially offset by growth in India and other regions.
Operational efficiency program delivered €500 million in FY26, with the full €1 billion target now expected by FY28, one year ahead of plan.
Free cash flow increased by 6% to €1.2 billion, with cash conversion at 91%.
Dividend maintained at €4.70 per share, with a final dividend of €2.35 offered in cash or shares.
Financial highlights
Net sales: €9,404m, down 3.9% organic and 14.2% reported, mainly due to currency and perimeter impacts.
Profit from recurring operations: €2,423m, down 5.2% organic and 17.9% reported.
EPS at €5.85, down 19% year-over-year.
Group share of net profit declined 26%, mainly due to higher non-recurring charges from restructuring.
Gross margin fell to 58.4%, down from 59.5%, due to adverse price/mix, tariffs, and COGS inflation.
Outlook and guidance
FY27 organic net sales expected to be broadly stable, with continued softness in the US and China, but ongoing strong growth in India and other markets.
Medium-term framework targets organic net sales growth at the lower end of +3% to +6% per annum through FY29.
Organic operating margin expansion expected, supported by €1 billion operational efficiencies by FY28.
Strategic investments capped at €700 million, with cash conversion targeted at 90%.
Net debt/EBITDA ratio targeted below 3x by FY29.
Latest events from Pernod Ricard
- Agile pricing, portfolio focus, and wholesaler realignment drive brand momentum and efficiency.RI
Investor Update - Distribution changes and data-driven strategies boost Power Six brands and RTD growth.RI
Investor update (Q&A) - Key brands outperform competitors as innovation and execution drive improved momentum.RI
Investor update - Q3 organic net sales rose 4.1%, but full-year sales are forecast to decline 3–4% amid FX headwinds.RI
Q3 2026 - Organic sales and profit declined, but free cash flow and debt metrics improved.RI
H1 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 2025 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 2024 - Q3 organic net sales fell 3%, but volumes rose and FY25 outlook and dividend were confirmed.RI
Q3 2025